accountDespite a ban on direct-to-consumer drug advertising in their country, Canadians have been exposed to more than $90...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,249 news
and
4,710 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
The world’s largest drugmaker, won dismissal of a false-claims lawsuit that alleged it illegally boosted sales through...
Drug-company executives are aiming to prevent steep cuts in prescription prices by joining the effort to overhaul the U.
Television ads for drugs and medical devices should avoid distracting images and music that can reduce viewers'...
Traditional drug development is still valuable to big pharmaceutical companies, as indicated by Johnson & Johnson...
M&A in the healthcare industry, particularly in the pharmaceutical/biotechnology sector, has maintained relatively...
The Vermont legislature has passed a law requiring drug and device makers to publicly disclose all money given to...
Fears over infectious outbreaks, from SARS to bird flu to the latest swine-borne virus, have boosted investment in...
You’ve probably heard the reports about drugs in our water that aren’t removed by traditional wastewater treatment.
Big Pharma spent 8% less in '08 on drug advertising than it did the prior year--a rare pullback.
The drug, Raptiva, has been linked with a rare but often fatal brain disorder.
Actemra is an anti-interleukin-6 receptor antibody and works in a different way than the existing...
The second big pharma merger of 2009 is a match many have predicted for years.
Harvard's med students are unhappy about their professors' conflicts of interest.
Pfizer Inc (PFE.N) said on Monday it will begin next year to disclose most payments made to doctors, joining a growing...
The Royal College of Physicians weighs in on the lack of innovation in the pharma industry.
The biotech giant has filed for approval of denosumab to treat osteoporosis.
Move over Big Three. Little Biotech is joining you in seeking federal assistance. Biotechnology industry executives...
pristine balance sheets and relatively little exposure to the credit markets, said Evan McCulloch, manager of the...
A new wave of consolidation could be on the way in the drug industry, as seven new CEOs look for new sources of growth.
good balance between drugs losing patent protection and experimental ones headed to market soon. But Moody's added that...
MS drug Tysabri might not pose as much of a side effect risk as feared.
Top Sources: Business of Biotechnology
- investorideas.com
- bioedgeconsulting.com
- Biotech Blog
- bloomberg.com
- News
- youtube.com
- contrarianprofits.com
- Forbes.com
- industry.bnet.com
- Health Beat
Post a Job
Jobs in this Topic
Senior Manager  Global Governance in Drug Development and Medical, Strategy & Business Operations
EMD Serono
|
Billerica, MA
Posted: May 22
Manager, Innovative Communications at Pharma/Biotech Internal Communications Agency
Kfs
|
Evansville, IN
Posted: May 3
SOFTWARE ENGINEER at exciting biotech company!
Adaptive Biotechnologies
|
Seattle, WA
Posted: Apr 19
Chief Medical Officer (CMO) for Pharma/Biotech
Epc Search International
|
North Carolina
Posted: Apr 18